G01N 2333/43513
From arachnidae
Official title: from arachnidae
G01N2333/43513 (From arachnidae) appears on 7 US grants and 9 published applications in this corpus.
Search patents in G01N- Granted patents
- 7
- Published applications
- 9
- Assignees
- 8
- Inventors
- 29
- Latest grant
- 4 Aug 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 3 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Use of La1-like peptide isolated from maurus palmatus venom as an activator of sperm motility in mammals4 Aug 2020US 10,729,745 B2Imv Technologies
- Dermatophagoides farinae protein29 Oct 2019US 10,457,711 B2Taiho Pharmaceutical Co., Ltd.
- Variant of mite allergen and uses thereof24 Sep 2013US 8,541,000 B2
- Methods for the delivery of toxins or enzymatically active portions thereof23 Jul 2013US 8,492,109 B2Trustees of Tufts College
- Inhibition of angiogenesis25 Jun 2013US 8,470,607 B2Morphotek, Inc.
- Use of la1-like peptide isolated from maurus palmatus venom as an activator of sperm motility in mammals23 May 2019US 2019/0151412 A1Imv Technologies
- Novel dermatophagoides farinae protein20 Sep 2018US 2018/0265556 A1Taiho Pharmaceutical Co., Ltd.
- Methods and compositions for cytometric detection of circulating tumor cell markers in a sample2 Mar 2017US 2017/0059569 A1
- Detection of tumor microenvironment with chlorotoxin conjugates19 Mar 2015US 2015/0080721 A1Blaze Bioscience, Inc.
- Methods for the delivery of toxins or enzymatically active portions thereof17 Oct 2013US 2013/0273590 A1Trustees of Tufts College
Most cited
By later US patents
- Treatment of human plasma with brown recluse spider toxin to emulate a lupus anticoagulant22US 4,877,741 AThe United States of America as represented by the Secretary of the Air Force · 1989
- Inhibition of angiogenesis13US 8,470,607 B2Morphotek, Inc. · 2013
- Methods for the delivery of toxins or enzymatically active portions thereof6US 8,492,109 B2Trustees of Tufts College · 2013
- Variant of mite allergen and uses thereof1US 8,541,000 B22013